The diagnostic value of the classifier was evaluated in HCC patients who were initially undetected by AFP or PIVKA-II testing, using cutoff values established in clinical practice (AFP at 20 ng/mL, PIVKA-II at 40 mAU/mL). Here, AFP is linked to hepatocellular carcinoma.